Literature DB >> 2555563

In vitro construction of poliovirus defective interfering particles.

K Hagino-Yamagishi1, A Nomoto.   

Abstract

To construct poliovirus defective interfering (DI) particles in vitro, we synthesized an RNA from a cloned poliovirus cDNA, pSM1(T7)1, which carried a deletion in the genome region corresponding to nucleotide positions 1663 to 2478 encoding viral capsid proteins, by using bacteriophage T7 RNA polymerase. The RNA was designed to retain the correct reading frame in nucleotide sequence downstream of the deletion. HeLa S3 monolayer cells were transfected with the deletion RNA and then superinfected with standard virus as a helper. The DI RNA was observed in the infected cells after three passages at high multiplicity of infection. The sequence analysis of RNA extracted from the purified DI particle clearly showed that this DI RNA had the same deletion in size and location as that in the RNA used for the transfection. Thus, we succeeded in construction of a poliovirus DI particle in vitro. To gain insight into the mechanism for DI generation, we constructed poliovirus cDNAs pSM1(T7)1a and pSM1(T7)1b that, in addition to the same deletion as that in pSM1(T7)1, had insertion sequences of 4 bases and 12 bases, respectively, at the corresponding nucleotide position, 2978. The RNA transcribed from pSM1(T7)1a was not a template for synthesis of poliovirus nonstructural proteins and therefore was inactive as an RNA replicon. On the other hand, the RNA from pSM1(T7)1b replicated properly in the transfected cells. Superinfection of the transfected cells with standard virus resulted in production of DI particles derived from pSM1(T7)1b and not from pSM1(T7)1a. These observations indicate that deletion RNAs that are inactive replicons have little or no possibility of being genomes of DI particles suggesting the existence of a nonstructural protein(s) that has an inclination to function as a cis-acting protein(s). The method described here will provide a useful technique to investigate genetic information essential for poliovirus replication.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555563      PMCID: PMC251205          DOI: 10.1128/JVI.63.12.5386-5392.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome.

Authors:  N Iizuka; M Kohara; K Hagino-Yamagishi; S Abe; T Komatsu; K Tago; M Arita; A Nomoto
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

2.  Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype.

Authors:  N Kawamura; M Kohara; S Abe; T Komatsu; K Tago; M Arita; A Nomoto
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

3.  Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase.

Authors:  S van der Werf; J Bradley; E Wimmer; F W Studier; J J Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  Defective interfering particles of poliovirus. I. Isolation and physical properties.

Authors:  C N Cole; D Smoler; E Wimmer; D Baltimore
Journal:  J Virol       Date:  1971-04       Impact factor: 5.103

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  Kinetic analysis of T7 RNA polymerase-promoter interactions with small synthetic promoters.

Authors:  C T Martin; J E Coleman
Journal:  Biochemistry       Date:  1987-05-19       Impact factor: 3.162

7.  A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.

Authors:  M Kohara; S Abe; T Komatsu; K Tago; M Arita; A Nomoto
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

8.  Vectors for selective expression of cloned DNAs by T7 RNA polymerase.

Authors:  A H Rosenberg; B N Lade; D S Chui; S W Lin; J J Dunn; F W Studier
Journal:  Gene       Date:  1987       Impact factor: 3.688

9.  Polyadenylic acid at the 3'-terminus of poliovirus RNA.

Authors:  Y Yogo; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

10.  Construction and characterization of poliovirus subgenomic replicons.

Authors:  G Kaplan; V R Racaniello
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

View more
  50 in total

1.  A poliovirus replicon containing the chloramphenicol acetyltransferase gene can be used to study the replication and encapsidation of poliovirus RNA.

Authors:  N Percy; W S Barclay; M Sullivan; J W Almond
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Replication of poliovirus RNA and subgenomic RNA transcripts in transfected cells.

Authors:  P S Collis; B J O'Donnell; D J Barton; J A Rogers; J B Flanegan
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  The fitness of defective interfering murine coronavirus DI-a and its derivatives is decreased by nonsense and frameshift mutations.

Authors:  R J de Groot; R G van der Most; W J Spaan
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

Review 4.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

5.  Evolution of poliovirus defective interfering particles expressing Gaussia luciferase.

Authors:  Yutong Song; Aniko V Paul; Eckard Wimmer
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

Review 6.  Molecular biology of hepatitis C virus.

Authors:  Tetsuro Suzuki; Hideki Aizaki; Kyoko Murakami; Ikuo Shoji; Takaji Wakita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

7.  trans rescue of a mutant poliovirus RNA polymerase function.

Authors:  W A Charini; C C Burns; E Ehrenfeld; B L Semler
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  A cis-acting function for the coronavirus leader in defective interfering RNA replication.

Authors:  R Y Chang; M A Hofmann; P B Sethna; D A Brian
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA.

Authors:  K Shiroki; T Ishii; T Aoki; M Kobashi; S Ohka; A Nomoto
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag.

Authors:  D C Porter; L R Melsen; R W Compans; C D Morrow
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.